5 months ago
LLY
AnalystsRajesh KumarRajesh Kumar's Stock Forecasts
AnalystsRajesh Kumar
Analyst Ranking
Top 32%
#1712 out of 5493 analysts
Average Return
+5.48%
Win Rate
48%12 out of 25
Risk vs Reward
Poor
Good
Rajesh Kumar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Eli Lilly & CoLLY | +111.01% | $449.46 | $948.40 | 2023-07-14 - 2024-07-12 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +106.12% | $10.13 | $20.88 | 2023-12-18 - 2024-12-17 | Strong Buy |
Regeneron Pharmaceuticals IncREGN | +22.80% | $649.81 | $797.99 | 2026-07-06 - 2026-08-12 | Strong Buy |
Iqvia Holdings IncIQV | +19.07% | $203.00 | $241.71 | 2025-10-09 - 2026-08-12 | Strong Buy |
Bristol Myers Squibb CoBMY | +17.63% | $61.94 | $51.02 | 2023-07-14 - 2023-10-27 | Sell |
Rajesh Kumar Analyst Color
Get additional color on Rajesh Kumar's coverage of popular stocks
10 months ago
NVO
a year ago
LLY
a year ago
LLY
a year ago
KDP
3 years ago
PFE
3 years ago
LLY
Rajesh Kumar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | $880.00 | +10.28% | Maintains | a month ago |
Zoetis IncZTS | 1 | Strong Buy | $95.00 | +29.18% | Maintains | a month ago |
Pfizer IncPFE | 3 | Hold | $28.00 | +6.42% | Downgrades | a month ago |
Danaher CorpDHR | 3 | Strong Buy | $230.00 | +11.76% | Maintains | 2 months ago |
Eli Lilly & CoLLY | 4 | Sell | $850.00 | -30.34% | Downgrades | 5 months ago |
Biogen IncBIIB | 2 | Sell | $150.00 | -28.18% | Maintains | 5 months ago |
Bristol Myers Squibb CoBMY | 3 | Hold | $60.00 | -5.81% | Maintains | 5 months ago |
Abbvie IncABBV | 5 | Strong Buy | $265.00 | +6.53% | Upgrades | 8 months ago |
Novo Nordisk A SNVO | 3 | Hold | N/A | N/A | Downgrades | 9 months ago |
Iqvia Holdings IncIQV | 2 | Strong Buy | $235.00 | -2.78% | Upgrades | 10 months ago |
Keurig Dr Pepper IncKDP | 1 | Strong Buy | $42.00 | N/A | Upgrades | a year ago |
Thermo Fisher Scientific IncTMO | 3 | Strong Buy | $670.00 | N/A | Maintains | 2 years ago |
Unitedhealth Group IncUNH | 2 | Hold | $460.00 | N/A | Upgrades | 2 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | 3 years ago |
Moderna IncMRNA | 1 | Sell | $97.00 | N/A | Initiates Coverage On | 3 years ago |
Biontech SeBNTX | 1 | Strong Buy | $124.00 | N/A | Initiates Coverage On | 3 years ago |
Merck & Co IncMRK | 1 | Hold | $123.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.